Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health

PJ Mogayzel Jr, ET Naureckas… - American journal of …, 2013 - atsjournals.org
Rationale: Cystic fibrosis (CF) is an autosomal recessive disease characterized by abnormal
airways secretions, chronic endobronchial infection, and progressive airway obstruction …

Treatment of pulmonary exacerbations in cystic fibrosis

JM Bhatt - European Respiratory Review, 2013 - Eur Respiratory Soc
Pulmonary exacerbations have very important consequences in cystic fibrosis (CF), both in
terms of current morbidity as well as implications for long term morbidity and mortality. Even …

Risk factors for bronchiectasis in children with cystic fibrosis

PD Sly, CL Gangell, L Chen, RS Ware… - … England Journal of …, 2013 - Mass Medical Soc
Background Bronchiectasis develops early in the course of cystic fibrosis, being detectable
in infants as young as 10 weeks of age, and is persistent and progressive. We sought to …

Omega‐3 fatty acids for cystic fibrosis

C Oliver, H Watson - Cochrane Database of Systematic …, 2013 - cochranelibrary.com
Background Studies suggest that a diet rich in omega‐3 essential fatty acids may have
beneficial anti‐inflammatory effects for chronic conditions such as cystic fibrosis. Objectives …

Antibiotic and anti-inflammatory therapies for cystic fibrosis

JF Chmiel, MW Konstan… - Cold Spring …, 2013 - perspectivesinmedicine.cshlp.org
Cystic fibrosis (CF) lung disease is characterized by chronic bacterial infection and an
unremitting inflammatory response, which are responsible for most of CF morbidity and …

New advances in the therapy of non-cystic fibrosis bronchiectasis

A Amorim, F Gamboa, P Azevedo - Revista Portuguesa de Pneumologia …, 2013 - Elsevier
Non-cystic fibrosis bronchiectasis remains a common and important respiratory disease to
date. It is a chronic pathology and consequently the patients usually require continuous …

[HTML][HTML] The role of Lipoxin A4 in cystic fibrosis lung disease

V Urbach, G Higgins, P Buchanan… - Computational and …, 2013 - Elsevier
Abstract In Cystic Fibrosis (CF), mutations of the CFTR gene result in defective Cl− secretion
and Na+ hyperabsorption by epithelia which leads to airway lumen dehydration and mucus …

Ибупрофен: безопасность и эффективность применения в широкой клинической практике

ТЕ Морозова, ТБ Андрущишина… - Терапевтический …, 2013 - cyberleninka.ru
В статье приводятся данные по фармакокинетике нестероидного
противовоспалительного средства (НПВС) ибупрофена, представлен обзор …

The role of endoscopy and biopsy in the management of severe gastrointestinal disease in cystic fibrosis patients

N Shah, H Tan, N Sebire, R Suri… - Pediatric …, 2013 - Wiley Online Library
There is increasing evidence to suggest the presence of chronic inflammation in the
gastrointestinal (GI) tract of cystic fibrosis (CF) patients. Some CF patients continue to have …

Ibuprofen: safety and efficiency of its use in wide clinical practice

TE Morozova, TB AndruShchishina… - Terapevticheskii …, 2013 - journals.eco-vector.com
The paper presents data on the pharmacokinetics of the nonsteroidal anti-inflammatory drug
ibuprofen and a review of the evidence base that suggests its clinical efficacy and safety in …